Literature DB >> 15093974

P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy.

Ozcan Ozdemir1, Mustasa Soylu, Ahmet Duran Demir, Serkan Topaloglu, Omer Alyan, Hasan Turhan, Asuman Bicer, Emine Kutuk.   

Abstract

Atrial fibrillation (AF) is the most common arrhythmia observed in hypertropic cardiomyopathy (HCM) and is associated with an acute deterioration. Recently, P wave dispersion (PWD) reflecting inhomogeneous atrial conduction has been proposed as being useful for the estimation of paroxysmal AF. In this study, we aimed to define the clinical, echocardiographic and electrocardiographic predictors for AF occurrence in patients with HCM. Twenty-seven patients diagnosed with HCM and having a history of documented AF attack were compared with 53 age- and gender-matched patients who had no such history. LA diameter was significantly greater and gradient in the left ventricle outflow tract was lower in patients with AF than those without AF. Maximum P-wave duration (Pmax), PWD and PTF1 values were significantly higher in patients with AF. A Pmax>134.5 ms separated the patients with AF from controls with a sensitivity of 92%, specificity of 89% and a positive predictive value of 80%. APWD value>52.5 ms separated patients from controls with a sensitivity of 96%, a specificity of 91% and a positive predictive accuracy of 84%. An LA diameter>4.2 cm separated patients from controls with a sensitivity of 96% and a specificity of 81%. We concluded that LA diameter and PWD values are the most significant predictors for AF occurrence in patients with HCM, and simply by measuring Pmax and PWD values, we could easily identify the patients with high risk, and prescribe the necessary treatment and follow-up protocols for such patients.

Entities:  

Mesh:

Year:  2004        PMID: 15093974     DOI: 10.1016/j.ijcard.2003.01.001

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  19 in total

1.  Effect of obesity on p-wave parameters in a Chinese population.

Authors:  Tong Liu; Zili Fu; Panagiotis Korantzopoulos; Xiaowei Zhang; Shaohua Wang; Guangping Li
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

2.  Noninvasive evaluation of reverse atrial remodeling after catheter ablation of atrial fibrillation by P wave dispersion.

Authors:  Yuhi Fujimoto; Kenji Yodogawa; Kenta Takahashi; Ippei Tsuboi; Hiroshi Hayashi; Shunsuke Uetake; Yu-Ki Iwasaki; Meiso Hayashi; Yasushi Miyauchi; Wataru Shimizu
Journal:  Heart Vessels       Date:  2017-06-19       Impact factor: 2.037

3.  Association of P-wave duration, dispersion, and terminal force in relation to P-wave axis among outpatients.

Authors:  Laxman Prajapat; Vignendra Ariyarajah; Mary E Frisella; Sirin Apiyasawat; David H Spodick
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

4.  Early electrocardiographic evaluation of atrial fibrillation risk in beta-thalassemia major patients.

Authors:  Vincenzo Russo; Anna Rago; Bruno Pannone; Federica Di Meo; Andrea Antonio Papa; Maria Carolina Mayer; Anna Spasiano; Maria Giovanna Russo; Paolo Golino; Raffaele Calabrò; Gerardo Nigro
Journal:  Int J Hematol       Date:  2011-03-10       Impact factor: 2.490

Review 5.  A primer on arrhythmias in patients with hypertrophic cardiomyopathy.

Authors:  Katy E Bockstall; Mark S Link
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

Review 6.  Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?

Authors:  Antonio Frontera; D G Wilson; H Sekhon; E R Duncan; G Thomas
Journal:  Clin Res Cardiol       Date:  2015-07-02       Impact factor: 5.460

Review 7.  Atrial fibrillation in hypertrophic cardiomyopathy: prevalence, clinical impact, and management.

Authors:  Lohit Garg; Manasvi Gupta; Syed Rafay Ali Sabzwari; Sahil Agrawal; Manyoo Agarwal; Talha Nazir; Jeffrey Gordon; Babak Bozorgnia; Matthew W Martinez
Journal:  Heart Fail Rev       Date:  2019-03       Impact factor: 4.214

8.  The amplitude of fibrillatory waves on leads aVF and V1 predicting the recurrence of persistent atrial fibrillation patients who underwent catheter ablation.

Authors:  Zhongwei Cheng; Hua Deng; Kang'an Cheng; Taibo Chen; Peng Gao; Min Yu; Quan Fang
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-01-20       Impact factor: 1.468

9.  Variable interatrial conduction illustrated in a hypertrophic cardiomyopathy population.

Authors:  Fredrik Holmqvist; Pyotr G Platonov; Jonas Carlson; Rasmus Havmöller; Johan E P Waktare; William J McKenna; S Bertil Olsson; Carl J Meurling
Journal:  Ann Noninvasive Electrocardiol       Date:  2007-07       Impact factor: 1.468

Review 10.  Predictors of Atrial Fibrillation Risk in Hypertrophic Cardiomyopathy.

Authors:  Kamil Tuluce; Selcen Yakar Tuluce
Journal:  J Atr Fibrillation       Date:  2015-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.